Polydextrose Functional Gummies for Weight Management in Adults With Overweight or Obesity
NCT07758387 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96
Last updated 2026-08-11
Summary
Overweight and obesity are common conditions that increase the risk of metabolic and cardiovascular diseases. Polydextrose is a type of dietary fiber that may help increase feelings of fullness by influencing natural hormones involved in appetite regulation. It may also improve postprandial glycemic responses and modulate the gut microbiota. However, evidence for its effectiveness in weight management remains limited.
The purpose of this study is to evaluate the efficacy and safety of functional gummies containing polydextrose compared with placebo in adults with overweight or obesity. Participants will be randomly assigned to receive either polydextrose or placebo gummies for 24 weeks, together with standardized dietary and physical activity recommendations.
The main objective is to determine whether polydextrose gummies produce a greater percentage reduction in body weight than placebo after 24 weeks. The study will also evaluate appetite and satiety, body composition, waist circumference, metabolic parameters, quality of life, gastrointestinal symptoms, and the safety and tolerability of the study product.
The study hypothesis is that daily consumption of polydextrose functional gummies for 24 weeks will result in greater weight loss than placebo and may improve subjective feelings of appetite and satiety in adults with overweight or obesity.
Conditions
- Obesity & Overweight
Interventions
- DIETARY_SUPPLEMENT
-
Polidextrose Gummies
Participants in the experimental group will consume the polydextrose gummies before each main meal (breakfast, lunch, and dinner) for 24 weeks. The daily dose will be gradually increased during the first week from 1 gummy before each meal (approximately 13.5 g of polydextrose per day) to 2 gummies before each meal (approximately 27 g/day). From week 4 onwards, participants with good gastrointestinal tolerability will increase to 3 gummies before each meal (approximately 40.5 g/day), while those with acceptable tolerability will remain at 2 gummies before each meal. Participants with poor tolerability will be withdrawn from the study. The gummies will be taken approximately 15-30 minutes before meals, preferably with a glass of water.
- DIETARY_SUPPLEMENT
-
Placebo Gummies
Participants in the control group will consume matching placebo gummies without polydextrose before each main meal (breakfast, lunch, and dinner) for 24 weeks. The daily dose will be gradually increased during the first week from 1 gummy before each meal (approximately 6 g of maltitol per day) to 2 gummies before each meal (approximately 12 g/day). From week 4 onwards, participants with good gastrointestinal tolerability will increase to 3 gummies before each meal (approximately 18 g/day), while those with acceptable tolerability will remain at 2 gummies before each meal. Participants with poor tolerability will be withdrawn from the study. The gummies will be taken approximately 15-30 minutes before meals, preferably with a glass of water. All participants will also receive standard dietary and physical activity recommendations.
Sponsors & Collaborators
-
Nutris We Care About You S.L.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-10-19
- Primary Completion
- 2027-10-29
- Completion
- 2027-10-29
Countries
- Spain
Study Locations
More Related Trials
-
Appetite Suppression Trial With Polydextrose
NCT02064205 ·Status: COMPLETED ·Phase: NA
-
Effect of Daily Glucomannan in Overweight Patients
NCT01485718 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Polyglucosamine Long Term Treatment
NCT02682277 ·Status: COMPLETED ·Phase: NA
-
Polyglucosamine L112 in Overweight and Obese Subjects
NCT05022732 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Subjective Ratings of Appetite and Glucoregulation of a Low Calorie Diet Supplemented With a High Viscosity Polysaccharide (PolyGlycopleX - PGX)
NCT01108328 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2).
NCT07165431 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of IQP- AK-102 in Reducing Body Weight
NCT01905956 ·Status: COMPLETED ·Phase: PHASE3
-
Polyphenol Supplementation and Morbid Obesity Parameters
NCT05428540 ·Status: COMPLETED ·Phase: NA
-
Effect of the Alpha-galacto-oligasaccharides on Weight Loss in Overweight or Moderately Obeses Adults : A Randomized Controlled Double Blinded Trial Versus Placebo
NCT02228746 ·Status: COMPLETED ·Phase: NA
-
Randomized Double Blind Placebo Controlled Clinical Trial to Evaluate Obese and Overweight Subjects
NCT04375696 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of a Bifidobacterium and Polydextrose on Body Fat Mass
NCT01978691 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Beta-glucan on Energy Intake and Satiety
NCT02637388 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Platycodon Grandiflorus Extract(GCWB107) on Decrease of Body Fat
NCT04023864 ·Status: UNKNOWN ·Phase: NA
-
Prebiotic Fiber as a Modifier of Satiety Hormones and Body Weight in Overweight and Obese Adults
NCT00522353 ·Status: COMPLETED ·Phase: NA
-
Polyphenols and Overfeeding
NCT02145780 ·Status: COMPLETED ·Phase: NA
-
Association of Probiotics With Neurostimulation of Dermatome T6: Effect on Weight Loss in Obese Patients
NCT03872245 ·Status: UNKNOWN ·Phase: PHASE3
-
Functional Bioactive Supplement Effect in Lost Weight Treatment
NCT02024425 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective Study Investigating the Effects of a Novel Weight Management Program
NCT01875354 ·Status: COMPLETED ·Phase: NA
-
Enriched Honey With Soluble Fiber and Polyphenols on Satiety and Dyslipidemia
NCT04153617 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Glucosanol™ in Body Weight Reduction
NCT02930668 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of IQP-AK-102 in Reducing Appetite
NCT02041754 ·Status: COMPLETED ·Phase: PHASE3
-
Beta-glucan and Insulin Sensitivity in Obese Humans
NCT01393210 ·Status: COMPLETED ·Phase: NA
-
Impact of Microbiome-changing Interventions on Food Decision-making
NCT05353504 ·Status: RECRUITING ·Phase: NA
-
Weight Regain After Consumption of Food Supplement and Interventional Diet Program
NCT03554525 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Beta-glucan Supplementation During Calorie and Carbohydrate-restricted Diet on Body Weight and Body Fat Loss, Appetite, and Gastrointestinal Appetite Hormones.
NCT07299942 ·Status: RECRUITING ·Phase: NA